Mixtard 20 (isophane insulin 80%/recombinant human insulin 20%) / Novo Nordisk - LARVOL DELTA

As Ozempic, Wegovy Take Priority, Novo Nordisk Winds Down insulin Portfolio In India (Medical Dialogues) - "Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand. The decision is part of the company's global strategy to prioritize newer, patented therapies such as Ozempic and Wegovy. The discontinuation will also affect products in the Rs 5,000 crore insulin market like Actrapid, Insulatard, Insulin Detemir, Levimir, and Xultophy, primarily available in pre-filled disposable pens and cartridges (prefill and FlexPen)."

Commercial • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus

Comparison of outcome of Daily use of Micro needling with topical insulin vs micro needling with intradermal platelet rich plasma once a month for treatment of post acne atrophic scars. (EADV 2024) - "Mixtard) 20 Units (0.5ml) on both sides daily night Preprocedural and post procedure blood glucose levels were measured... Daily use of Micro-needling along with insulin appears to show better outcome than monthly sessions of micro-needling with PRP for the treatment of acne scars. The result could also widely depend on the daily use of microneedling in group A with topical insulin in comparison to the monthly use of microneedling with PRP in Group B This combination procedure does not require expensive equipment and could be done in all skin type patients as post-inflammatory hyperpigmentation is rarely seen after the therapy. Also, this novel combination procedure is convenient for both doctors and patients as no high skills are required, no need to take I/V line and less time consuming."

Acne Vulgaris • Anesthesia